Contact: April Stuart (405) 319-8260 astuart@phfokc.com FOR IMMEDIATE RELEASE OKLAHOMA CITY, July 20, 2020: The Presbyterian Health Foundation has awarded nearly $4.6 million in biomedical research grants to the University of Oklahoma Health Sciences Center (OUHSC) and the Oklahoma Medical Research Foundation (OMRF). “We remain steadfastly committed to funding cutting-edge biomedical research on theRead more
The University of Oklahoma Health Sciences Center (OUHSC) in Oklahoma City is a major contributor to scientific advancement and the state’s biosciences industry. With seven colleges situated on one academic medical campus, as well as robust basic science, clinical and translational research programs, OUHSC is proud to conduct life-changing research that also benefits the stateRead more
JULY 17, 2017 — The Presbyterian Health Foundation has awarded $3.73 million in new grants to the University of Oklahoma Health Sciences Center and OMRF. The grants will support more than 30 research and clinical projects, purchase scientific equipment and provide a recruitment package for a new senior-level researcher. “As biomedical research grants become exceedinglyRead more
By Paula Burkes Copyright © 2016, The Oklahoma Publishing Co. Most scientists spend a lifetime hoping their research contributes to a body of work that collectively will lead to a new drug that will treat or cure a disease. For Oklahoma Medical Research Foundation’s Rodger “Rod” McEver, that body of knowledge was developed in hisRead more
In October, the Brookings Institute announced Oklahoma City as one of two pilot cities that are part of a study into developing an Innovation District. It already has held informational meetings and tours to gather ideas on just what that might look like.
Biolytx Pharmaceuticals picks up $1.1 mill By Iris Dorbian © 2015 Buyouts Insider / Argosy Group LLC OKLAHOMA CITY, OK — A $500,000 investment from the i2E, Inc.-managed Oklahoma Seed Capital Fund recently led a $1.1 million financing round in Oklahoma City-based Biolytx Pharmaceuticals Corp. Biolytx is developing a promising drug designed to promote woundRead more
By Jim Stafford Copyright © 2015 The Oklahoma Publishing Company My mother adored “Dr. Kildare.” In the mid-1960s it was, as they say, appointment television viewing in our house. I think it had to do more with the appeal of Richard Chamberlain and less with the medical cases he solved on a weekly basis. Millions ofRead more